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Abstract
Malaria is a leading cause of death in Sub-Saharan Africa. Tanzania changed its malaria treatment policy
from chloroquine (CQ) to Sulphadoxine-Pyrimethamine (SP) as first line drug in August 2001. We wanted
to assess the perception and behaviour about SP after phasing out chloroquine which was very popular,
cheap, available, and was preferred by many people for self-medication in homes as it was considered to
have minimal side effects.
Focus Group Discussions (FGDs) were carried out after one year of the anti-malarial drug treatment
policy change in the country. The FGD themes were on malaria for under-five children and other age
groups, anti-malarial drug use through self-medications, specific experiences people had about SP drug for
both mothers/guardians, men in the communities and health workers. A total of twelve FGDs were
performed with mothers/guardians, men and health workers in the selected public health care facilities in
the district.
In the FGDs people feared adverse reactions from SP; its slow ability of reducing fever and self-treatment
in this case was less reported from the mothers/guardians groups. However, SP was reported by health
workers to be administered using the direct observation approach under supervision in their health care
facilities. This was done in order to increase compliance as there were worries that some mothers were
throwing away the drug if they were instructed by health workers to go and administer SP to their sick
children at home.
Based on this information, it is obvious that fear and negative perceptions about SP drug was common in
the study setting. As evidence of this, there was less reported home-stocking and self-medication in the
discussions for this particular recommended new first-line anti-malarial. The public has demonstrated a
lack of confidence in SP. Furthermore, some health workers expressed obvious fear and negative
perceptions towards the drug despite the fact that some FGDs with health workers considered the drug
to be good and effective against malaria. Such negative perception towards SP highlights the need to start
earlier sensitization and educational campaigns to the rural communities for a new drug program to ensure
its success. Messages should clearly state what should be expected from the new drug (Coartem), before
its introduction. This is important especially as Tanzania is expected to move towards the expensive but
efficacious and effective fixed-combination (Coartem) anti-malarial therapy early next year (2006).
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Worldwide, malaria causes more than 1.5–3 million
deaths each year of which more than 90% occur in under-
five children in sub-Saharan Africa [1]. The majority of
those are among the children who have not developed
adequate immunity to the parasite and also in pregnant
women. However, malaria is on the increase due to
changes in the environment, the collapse of health sys-
tems in areas of civil strife and war, growing resistance of
malaria to affordable anti-malarial drugs and limitations
in national health services.
Despite many attempts to eradicate or control malaria, the
disease still threatens about 40% of the world populations
(300–900 million cases every year). Malaria is endemic in
almost all parts of Tanzania, and it accounts for over 30–
40% of the disease burden (admissions and outpatient
attendances). It is a major cause of under-five mortality
and morbidity. About 70,000–100,000 under-five deaths
which occur annually in the country are due to malaria
[2]. Malaria is a threat to every one as it affects all age
groups but under-fives, pregnant women and non-
immune individuals are more vulnerable than others. The
cause of death in these vulnerable groups is mostly due to
cerebral complications and anaemia especially in under-
fives children and pregnant women. Malaria is also a
major contributor to maternal deaths and low birth
weights of children [3].
Chloroquine (CQ) has been used for many years as first
line treatment drug for uncomplicated malaria in many
sub-Saharan countries including Tanzania. Nevertheless,
because of rapid development and spread of resistance to
the drug in African countries, these countries have been
forced to change their anti-malarial drug treatment poli-
cies to sulfadoxine-pyrimethamine (SP). However, it is
very unfortunate that even to this newly recommended
drug (SP) resistance is reported to be developing very fast
in most places of sub-Saharan countries [4,5]. So far when
Tanzania changed its anti-malarial drug treatment policy
to SP in August, 2001, chloroquine resistance was more
than 42% [6].
The widespread self-medication practices for most febrile
illnesses is a known major problem in sub-Saharan coun-
tries [7]. Such irrational self-treatment practice is reported
to be accompanied with either over-or-under-dosages [8],
with an increased risk of toxicity or emergence and wide-
spread development of drug resistance [9]. Furthermore,
SP is reported to be expensive in terms of price when com-
pared to chloroquine in Tanzania [10].
Tanzania is a country heavily affected by malaria, as it
combines widespread prevalence of the malaria mosquito
with low levels of government and community resources
available to combat the disease. Over 75% of Tanzania's
35 million people live in areas where malaria is highly
endemic (transmission period longer than 4 months per
year), and the estimated number of cases is between 14–
18 million annually. Next to the enormous loss of pro-
ductivity due to illness and the costs of treatment, malaria
results in an estimated 100,000 to 125,000 deaths per
year, of which 70% are children under the age of five [2].
For Tanzania, malaria is not just a health issue, but a
national development problem.
Tanzania has made malaria control a priority and is an
active partner in the global Roll Back Malaria (RBM) part-
nership, set up by the WHO in 1998. Comprehensive
malaria control policies have been formulated by the
National Malaria Control Program, a large number of
pilot projects have been implemented, national first-line
drug treatment for malaria was changed in August, 2001
to Sulfadoxine-Pyrimethamine (SP) to overcome chloro-
quine resistance. Despite these efforts, much remains to
be done as local governments and poor rural communi-
ties lack resources to implement successful malaria con-
trol programs.
Thus, it was necessary to study how SP was perceived by
both the mothers/guardians, men in the communities
and health workers who are entrusted with providing care
to these communities within their catchment areas. SP
was introduced after the government (Ministry of Health)
decided to phase out chloroquine from being used as first-
line-anti-malarial for treatment of uncomplicated malaria
for all age groups in Tanzania. The aim of this study was
to access people's perceptions, compliance, self-medica-
tion practices (rational use of SP), household responsibil-
ities in case of sickness and source(s) of information
about SP. This study also aimed at forming basis for insti-
tuting interventions to improve compliance and rational
drug use practices which may help in prolonging the life
span of the available first line anti-malarial drug in the
country. Such rational practices if achieved would also
increase the cure rates and reduce treatment failures.
Furthermore, Tanzania will early next year (2006) be
replacing SP with an expensive but efficacious and effec-
tive fixed-anti-malarial-combination of artemether and
lumefantrine therapy (Coartem). This new fixed combi-
nation drug will need its life span be preserved so that it
remains in use for at least the same duration or more than
what chloroquine served over 40 years in Tanzania.
Materials and methods
Study area
The study was conducted in Kibaha district, Coast region-
Tanzania. The district is located 40 km north-west of Dar
es Salaam, Tanzania. The district was chosen becausePage 2 of 8
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is also geographically accessible from Dar-es-Salaam the
economical capital of the country. According to the
National Census of 2002, Kibaha district has a total pop-
ulation of 132,443 people [11].
Selection of study population
A three-stage cluster sampling procedure was used in the
selection of wards, hamlets and households. Our sam-
pling framework was based on the administrative struc-
ture of the Kibaha district. In Tanzania, all districts have
divisions, and divisions are subdivided into wards. In
urban areas, wards were further subdivided into hamlets
(vitongoji), whereas, in rural settings, wards were subdi-
vided into villages and the villages were further subdi-
vided into hamlets.
The district had a total of 9 wards and of these 4 were
urban and 5 were rural. After listing all the wards, then
two rural and two urban wards were randomly selected. A
list of the villages and hamlets in the chosen wards was
obtained from the District Planning Officer (DPO).
A total of 12 focus group discussions consisted of 6–10
participants each were held, four with mothers, four with
men and four with health workers. The participants in the
mother's/men focus groups were chosen with help from
the ward secretaries and the district nursing officer for the
health worker focus groups. The mothers and men and
health workers were aged between 18–50 years. Most of
them had completed primary school education. The
health workers FGD groups were divided according to
their educational level and their training background.
Table 1: Shows summaries of statements made by different focus group discussions (4 FGDs) with mother's/guardian's about SP
About SP Why switch to SP? How can the situation 
be improved?
Who's responsibility to 
care the sick child?
What's wrong with the 
media?
- SP is mixture of all drugs 
like Fansidar.
- SP is not good because it 
causes: swelling, body 
rashes, children dying.
- We are afraid of using it 
because it is too strong and 
kills people.
- My son became like a 
cobra-snake and got black 
like a charcoal after using 
SP.
- SP has no side-effects to 
me and when I use it cures 
my malaria.
-SP is a good drug, my son 
used it and has never fallen 
sick again.
- The drug is too strong 
and one needs to eat 
enough food.
- People are afraid of using 
the drug and we hate it and 
we don't give our children 
when they give us at the 
hospital.
- Now we are being forced 
at the hospital to give our 
children the drug under 
supervision of nurses.
-Parasite are resistant to 
CQ.
-SP is on research trial by 
the government.
- They want to see how 
many people will be killed 
by the drug.
- If drug was good, we 
would not find it plenty in 
our hospitals.
- We have nothing to do, 
but agree with what the 
government gives us as we 
are forced to use the drug.
- The Ministry of Health 
should work hard on 
sensitizing and educating 
the people.
- If you tell the doctors that 
you don't use SP he/she 
may listen to you and give 
an alternative drug or not 
it depends.
- We are treated with SP at 
the facilities for all illnesses.
- Doctors don't ask 
whether don't use SP.
- More research has to be 
done how to lower the 
dose and what causes these 
side effects.
- Educate people first about 
SP before introducing for 
large scale use.
- Nurses should educate 
mother's on how to take 
this drug and about side 
effects to be expected.
- Educate the news writers 
about the drug.
- The sulfa component 
should be removed from 
SP.
- We want doctors and 
nurses to properly inform 
us how to use SP whether 
without eating etc
- Nurses and doctors 
should be given seminars 
on how to properly treat 
malaria.
- Doctors should listen 
carefully to patients so that 
they can reduce the dose 
as the drug is too strong 
for weak people.
- Put in place drugs which 
are less strong for mild to 
moderate malaria and 
reserve SP for severe 
cases.
- When the children are 
sick we mothers take them 
to hospital.
- Father's directs us not to 
take SP.
- Father work to get 
money and most of the 
time they are out but they 
provide money.
- If the father is not at 
home and the child is sick I 
can't wait, I go myself to 
hospital or take any other 
immediate actions.
- We mother's are first 
child's doctors in our 
homes.
- Some men are lazy and 
sometimes they are drunk 
and do not care about the 
child.
- Most fathers' get involved 
when the child is seriously 
ill.
- At times we discuss with 
our husband's if they are at 
home, otherwise we brief 
them what transpired 
when they were not 
around.
- In most cases we involve 
them if the child's 
condition gets worse.
- The father mostly gives 
you money to go and buy 
drugs or as bus fare to 
send the child to hospital 
and very rarely they escort 
you.
- SP is advertised so much 
in newspapers, radio and 
television.
- They show people who 
gets affected by the drug 
after using it.
- They also put a name and 
a picture of a person who 
has been affected by SP.
- These news scare a lot of 
people who see or read 
them.
- We also here in radio 
that chloroquine is no 
longer working in treating 
malaria.Page 3 of 8
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clinical officers (COs & ACOs)), one group of trained
nurses and two groups consisted of nurse assistants.
Data collection
Focus group discussions (FGDs)
Guided themes for the FGDs were developed using the
Swahili language (National language spoken by most Tan-
zanians) and were pre-tested before carrying out the
actual study. The themes included self-medication prac-
tices with SP and other different anti-malarials, percep-
tions toward SP, any untoward experiences with SP or
rumours they have heard about the drug and from which
source. The discussions were held in undisturbed loca-
tions with one moderator who was an experienced social
scientist from the Department of Sociology, University of
Dar-es-Salaam. He was assisted by the PI and the main
author (SN). Note taking was done by two graduate social
scientists who had just completed their Masters of Arts in
Sociology at the University of Dar-es-Salaam. All discus-
sions were tape recorded and later on transcribed from the
Swahili version into English. The translation into English
included also the Swahili hand written notes. This transla-
tion was done by the author (SN) and one of the note
taker (DS).
The FGD approach was used for data collection because it
allows the researchers to get ideas about peoples experi-
ence, opinions, beliefs and participants' responses can be
presented with actual quotes that helps the reader to get
the main ideas or messages. Furthermore, it gives oppor-
tunity to observe the interactions within the groups which
is normally lacking with interviews.
Data analysis
The focus group discussions were analysed using a combi-
nation of qualitative approaches or methods [12] which
also included coding and structuring the data into catego-
ries [13]. Furthermore, analysis also used the traditional
interpretive understanding approach [14]. This analysis is
Table 2: Shows summaries of statements made by different focus group discussions (4 FGDs) with men about SP
About SP Why switch to SP? How can the situation 
be improved?
Who's responsibility to 
care the sick child?
What's wrong with the 
media?
- People who had 
experienced side effects 
due to SP can never use 
the drug again in their life 
time.
-Most people fear using SP 
because they think it is not 
a good drug. health 
facilities because people 
don't use the drug may be 
unless you force them
-When one takes the drug 
needs to eat a enough food 
and drink a lot of water
-Few people get side 
effects due to SP and 
actually it is not easy to tell 
if really what people 
complain is due to SP.
-A lot of people are 
affected by and many have 
died.
-Children who use SP get 
very weak, tired, and some 
become confused.
- In general SP cures better 
than chloroquine and it is a 
good drug except of its 
minor problems it causes
-SP is a combination of 
Fansidar, Metakelfin and 
Septrin.
-Even if you tell the doctor 
that you don't have malaria 
still you will get SP 
prescribed.
- These drugs are still on 
trial and this is bad to play 
with peoples lives.
- Sometime when you ask 
the doctors about SP they 
become harsh and they 
think that you are trying to 
teach them their job.
-These days doctors don't 
pay much attention to 
patients as they mind their 
own business and less time 
for patients.
- It is up to the Ministry of 
Health and experts to 
decide what should be 
done regarding malaria 
treatment.
- Find preventive measures 
against malaria and more 
research on SP is needed.
- More efforts should be 
done to inform and 
educate the people about 
the drug.
- There is a need to 
improve laboratory 
facilities so that people 
should be checked for 
malaria parasites before 
they are given or 
prescribed SP.
- There is a need to have 
SP injection formulation.
- SP dosage should be 
reduced especially for 
under-five children as the 
drug is too strong though it 
is a good one.
- Radio and newspapers 
should help in educating 
people.
-SP should be removed 
from use and chloroquine 
be brought back
-Doctors should be 
educated on measuring 
weight of patients before 
prescribing SP and should 
check who to give SP.
- All married men take 
responsibilities as children 
are our only investment.
- Most decisions involving 
finances are done by men 
and if the father is not 
around the wife takes the 
task in the absence of the 
husband.
- Many women prefer to 
start with traditional 
healers for a seriously sick 
child.
-Even if the husband is a 
drinker, when one gets 
home we normally ask if 
things are in order. As the 
father is a bread earner in 
most households.
- The wife takes care of the 
children and the father 
looks for money to feed 
the family.
- Sometimes we men take 
the responsibility of helping 
our wives to take a sick 
child to hospital or go 
together if we around 
home.
- Most father's can not 
leave his/her sick child 
dying without helping each 
other at home.
-We father's participate 
especially if the sick child is 
above 5 years and mother's 
deal with sick under-fives.
- These news people are 
making business sometime 
by writing misleading 
information about SP.
- So people need to be 
careful when reading 
newspapers or watching 
television or listening to 
the radio.
- These media do not give 
or talk about the positive 
aspects of the drug instead 
they just talk of the 
negative aspects of SP.
- You will find that most of 
the side effects of SP we 
have heard or seen them 
shown in newspapers, 
radios and televisions.
-Even pictures of affected 
individuals by SP are shown 
on televisions and 
newspapers.
- In our village or 
community we have not 
yet experienced any 
person so far getting 
problems with SP but have 
only read in newspapers.Page 4 of 8
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through eliciting meanings and responses the study par-
ticipants gave during the FGDs. A code sheet was created
following the focus group guide and data were coded.
Then a master sheet was done giving listing of all the
responses from the focus groups. These responses were
interpreted by looking at their patterns. Finally sorting
and sifting through information, looking for patterns,
consensus, differences, variations or contradictions and
weighing the relative importance of information compli-
mented the interpretative understanding. Raking and tab-
ulation of the data was also done.
Ethical Approval
Ethical approval was obtained from the human ethics
committees of the Muhimbili University College of
Health Sciences and from the Kibaha district, Coast
Region administrative authorities, ward secretaries, village
chairmen and leaders of the hamlets.
Results
Knowledge about "SP"
Focus group discussions (FGDs), revealed some knowl-
edge about the drug (SP) and it's use. Some participants
reported that malaria parasites were resistant (in a Swahili
Table 3: Summaries of statements made by different focus groups discussions (4 FGDs) with health workers about SP
About SP Why switch to SP? How can the situation be 
improved?
What's wrong with the media?
- Is a drug containing sulfadoxine 
and pyrimethamine.
- We know that some symptoms 
are caused by SP others not.
- Some mothers throw away SP 
tablets when we give them to 
administer for their sick children at 
home.
- So we decided to administer SP 
for all sick children at our facilities 
under supervision of a health 
worker.
- The drug delays relief of fever 
symptoms and people interpret it 
as side effects.
- We are not certain whether all 
these side effects being spoken 
about are really caused by SP or by 
other things? These rumours have 
created a lot of fear.
- It is true that SP causes skin 
rashes, itching, dizziness, headache 
and some body weakness. 
However, some people who are 
allergic to SP may react badly even 
die if no immediate help is given.
- The number of people using SP at 
our facilities is decreasing daily and 
as a result we are left with a lot of 
SP drugs every month.
- People claim to get side effects 
and even leading to sores, loss of 
appetite, skin colour changes to 
black as a charcoal in some 
individuals.
- Those who are given SP and they 
throw away they usually come 
back the next day or after two 
days complaining of malaria and 
that SP did not work.
- We try to educate and convince 
them about the drug, but some 
clients are difficult to understand
-People think that we are forcing 
them to use SP.
- People believe that as health 
workers we know everything of 
what is going on about the drug 
whether it is being on trial or not.
- When patients come to the 
facility, they choose the doctor 
they want if we happen to be two 
or more because they would like 
to be attended by some one they 
know they can convenience not to 
be prescribed SP.
- Some of them lie that I am 
allergic to SP so that they can be 
prescribed an alternative drug.
- Some Members of Parliament 
have also contributed to people's 
fear about SP because they have 
been questioning the Minister for 
Health about this drug during the 
parliament session.
-Some patients do not seem to 
trust the water we give them to 
swallow with the drug for their 
under-five children.
- Member of Parliament and other 
ordinary people should be 
educated about this drug.
- Some patients we see suggest to 
us that the sulphur content should 
be reduced from SP as they think 
this is the one which is causing all 
the side effects and making also 
the drug strong
- Others suggest that chloroquine 
should be brought back in use.
- The Ministry of Health should do 
more research to find out why the 
drug is too strong or what makes 
it be strong and other side effects 
– The drug needs to be taken 
together with Paracetamol which 
is an antipyretic to help reduce the 
fever.
- Educate the news writers or 
reporters about the drug so that 
they write proper messages.
- Families need counseling 
especially those who experience 
or had experienced SP side effects.
- Patients who get skin problems 
as a result of SP we give them 
hydrocortisone.
- We repeat the dose if the patient 
returns to us complaining of no 
improvement for the first time 
since we last gave SP.
- The sulphur content should be 
investigated more by experts.
- SP should remain in use but be 
improved.
- Patients should eat and drink a 
lot of water when taking or after 
have taken the drug.
- Less educated news writers 
magnify stories with SP side 
effects.
- These SP stories through media 
have caused a lot of fear and 
negative perception about the drug 
in the general population.
- Radio report that SP kills and 
some newspaper displays pictures 
of affected individuals and hence 
causing more fear to people when 
they see.
- Radio and newspaper are most of 
the time broadcasting problems 
related to SP with is not based on 
truth and no positive images about 
the drug.Page 5 of 8
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FGDs reported "sisi tunalazimishwa tukutunia hii dawa ya
SP kwa sababu klorokwini haipo kwenye maduka ya dawa"
[our translation] they are forced to use SP in public health
facilities and CQ is not available in drug stores or shops.
Some said "sisi tungependa kuendelea kutumia klorokwini
kama ingekuwa ni hiari ya mtu kuchagua kwani bado
tunaamini inaweza kutibu malaria" [english translation]
they would have liked to continue using CQ if they were
given freedom to chose as they strongly believed CQ was
still effective for malaria treatment (Tables 1 &2).
In all the FGDs, participants mentioned they had heard
about the new drug (SP) on the radio, some few in news
papers and the majority were those who had visited health
facilities previously and were either informed by the
health care workers or they read about it on posters posted
on the walls at the health care facilities.
Experience with "SP"
In the FGDs, most participants expressed a lot of fear and
worries about using SP due to reported adverse reactions.
Few had actual experience of such reactions, but everyone
had heard about people who died after using SP. In one of
the FGDs with men, one participant stated that "hii dawa
ni nzuri kwani haina madhara mengi kama watu wanavy-
osema au kufikiria kwani mimi nimeitumia sikupata madhara
yeyote" [english translation] side effects due to SP use are
rare in occurrence and he had used the drug and found it
was a good one and never got any side effects (Tables 1, 2,
3).
Others commented that "SP ni dawa mbaya sana kwa
sababu inaua, inaunguza ngozi mwilini au inababua au kuc-
huna kabisa ngozi na haishushi homa haraka badala yake ina-
pandisha homa na kwa ujumla ni dawa ambayo ina nguvu
sana hasa ukiitumia kwa mtoto au watoto" [english transla-
tion] it is a bad drug as it kills, burns the skin, it does not
reduce the fever or temperature and it is too strong espe-
cially when used for children.
Furthermore, during the FGDs, some participants with
mothers and men were very angry and thought they were
part of an experiment staged by the Tanzanian govern-
ment to see how the drug kills or how many people would
be killed by using SP [Swahili translation] "serikali yetu
imeamua kufanyia majaribio hii dawa ya SP kwetu ili waone
kama watu wangapi watakufa" (Tables 1 &2).
The mass media
Participants in all FGDs, had heard about severe adverse
reactions through mass media, most commonly newspa-
pers and radio. Several participants suggested that
"waandishi wa habari lazima waelimishwe namna ya kuan-
dika habari zinazohusu madawa vizuri hasa dawa hii ya SP
kwani wanavyoandika kwenye magazeti na watu wakasoma na
kuona picha ya mtu aliyeunguzwa na dawa hii kila mtu
anaogopa na kusema hataitumia hii dawa" [english transla-
tion] the news media or writers should be educated about
SP drug and how to write proper medical news or infor-
mation in the correct way which will not scare the audi-
ence when they read. They went further to say information
is very important as it may build or destroy the image of
the drug. Once people have read or heard about it, it is dif-
ficult to change their mind back (Tables 1, 2, 3).
Healthcare workers observations and experience
Because of the fear and negative perception about SP, all
FGDs with health workers explained "kwa sababu ya kuona
watu wanaiogopa hii dawa na akina mama wengi wakipewa
wakampatie moto SP nyumbani wengine wanaitupa njiani
hivyo tumeamua watoto wote wenye homa tunawapatia SP
wameze hapa hapa hospitalini na tunamwangalia moto kwa
muda wa nusu saa, kama hajatapika ndipo tunamruhusu
mama aende na moto nyumbani na akitapika tunarudia tena
kumpatia dawa" [english translation] they had to give the
drug under observation in the health facility to avoid
mothers throwing away the drug (SP tablets) on their way
home instead of giving them to their sick children (Table
3). To combat this practice, the child was made to swallow
the drug in the presence of a healthcare worker and was
observed for 30 min before being allowed to go home in
order to make sure the child did not vomit the drug. This
practice of the healthcare workers was confirmed by FGDs
with mothers. The DOT for SP in under-five children was
applied in these facilities and if the child vomited within
this period another dose was administered by the health
worker (Table 1).
Discussion
Sulfadoxine-Primethamine (SP) was previously reported
to be too strong for children in the same district [10] and
that the drug had characteristic properties of rapidly clear-
ing parasites but slow fever clearance [15]. From the FGDs
it was revealed that people knew that SP was available and
was used as a first line drug for treatment of malaria. How-
ever, other FGDs reported that the drug (SP) increases
fever and makes the general body weak after taking the
drug.
In spite of the described negative perceptions about SP,
the drug was used in these communities. However, expe-
rience from African countries like Malawi and Kenya
which introduced SP as first line treatment shows that
people continue to use chloroquine after the introduction
of the new drug due to scepticism about the efficacy of the
new drug or fear that "a potent" drug could be dangerous
[16]. With such a change in anti-malarial drug policy,
mothers/guardians had no option except to seek care at
the public health care facilities. However, this health seek-Page 6 of 8
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with other consequences related to personal, social and
economic problems. For example walking distances and
long waiting time must be considered as factors which
may affect treatment. These delays prevent children from
getting early diagnosis and prompt treatment with first
line anti-malarials as advocated by the Roll Back Malaria
(RBM), the Integrated Management of Childhood Ill-
nesses (IMCI) and Home Based Management of Fever
(HBMF) [17].
In general our results from the FGDs with mothers/guard-
ians and men revealed some good awareness about SP
despite the fact that some of them were hesitant in accept-
ing the drug. All these fears, negative perception about the
drug are due to several factors such as; its slow pharmaco-
logical effects or actions in providing quick relief of fever
symptoms, instead it takes up to three days to resolve the
fever. Secondly, because of the reported rare but serious
side effects which occur to some individuals being
reported through mass media. This rare side effect is med-
ically known as Steven's Johnson's Syndrome.
Futhermore, FGDs with mothers and men gave strong
statements about the drug such as "our government has
decided to use this drug (SP) for experimental or research
purposes so that they can see how it kills or how many
people will be killed after using this drug. They went on
further to say "SP is a bad drug as it kills, produces adverse
skin reactions, does not reduce the fever, and instead
raises, and was too strong for children". These are strong
allegations to the government (Ministry of Health) which
are not true per se because no government would subject
her people to a harmful drug. These comments show how
some groups of participants were illiterate or not well
informed about the drug (SP) properties or actions.
A concern regarding SP raising fever for children was dis-
cussed on several occasions in the FGD groups. The other
negative effects about the drug included fear of side
effects, burning the skin or producing blisters. Thus, the
drug was negatively perceived in that way. Some FGDs
with mothers/guardians clearly reported that they were
forced to use SP in public health care facilities. Neverthe-
less, they used the drug because chloroquine was no
longer available. In their opinion, they would have liked
to continue using CQ as they believed the drug was still
effective in treating malaria.
FGDs with healthcare workers reported using a direct
observation therapy (DOT) when administering SP to the
sick under-five children in health care facilities. This DOT
approach was stated also by mothers FGDs. This DOT
approach is important because mothers who fear and
have negative impressions of the drug can not administer
the given drug at home. Instead they may give an ineffi-
cient substitute or not give anything to the sick child. This
is a dangerous practice as it allows the disease to progress
from mild to severe forms. The severe form of the disease
for a sick under-five child in most cases is accompanied
with fatal consequences or outcomes such as cerebral
malaria, anaemia or death. Sadly, you may find these
mothers coming back to the facilities on the following day
or after one to two days complaining that the drug did not
work while in fact they never administered it to the sick
child.
Previous studies reported lack of anti-malarials at public
health care facilities especially during the chloroquine era
[18,19]. However, SP was available and free of charge for
all sick under-five children in Tanzania. The possible rea-
son why SP was available as reported by FGDs with
healthcare workers was because they received the same
number of tins (quantities of SP) as during the chloro-
quine era in public facilities. SP is given as a single dose as
compared to chloroquine which was administered spread
over 3 days. The anti-malarial fixed combination therapy
(Coartem) which Tanzania will be changing to early next
year (2006), has the dosage schedule spread over 3 days
like chloroquine which may compromise compliance.
Perhaps it is important to consider and plan to order more
tins of the new drug as it will be given on a 3 day regimen.
Otherwise, we could repeat the problem previously expe-
rienced with chloroquine. That is the new drug (Coartem)
being not readily accessible and available all the time in
most primary health care facilities in the country.
However, SP is expensive as it costs 5–11 times the price
of CQ [10]. If this drug was not given free at the public
facilities, the poor Tanzanians, especially in rural commu-
nities, would not have been able to purchase the drug and
this would result in poor treatment seeking behaviour for
malaria [20-22]. Due to fast development of resistance to
SP, Tanzania will soon be moving from SP (mono-
therapy) to an expensive fixed combination anti-malarial
therapy that is ten-times more expensive than SP. A full
course or dose of artemether-lumefantrine (Coartem) will
cost 6,000–10,000 Tanzania shillings (equivalent to 6–
10$). Initially the drug will be given free of charge for a
period of about 3 years or more through the Global Fund
(GF) support. Thus, this calls for concerted efforts to be
put in place by the National Malaria Control Program
within the Ministry of Health to properly educate the peo-
ple on rational practices of using this drug once it
becomes officially available. Rational use of this fixed
combination drug will help to prolong the life span of this
expensive medication.
SP was reported to be in use through FGDs in spite of the
reported fear and wide spread negative perceptions aboutPage 7 of 8
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the drugs side effects. Thus, any future anti-malarial drug
treatment change in the country, should consider the
practical aspects of community involvement and accept-
ance of any new anti-malarial drug to be introduced. The
implementation phase should focus more on community
sensitisation of the people using various communication
approaches or strategies such as use of mass media, news,
radio and television. These communication strategies
should bear correct, relevant, and short clear messages.
Sensitizing and educating the people to raise their knowl-
edge and awareness is of paramount importance for the
success of the program.
However, the commonest reported media were newspa-
pers and radio and on rare occasion television was men-
tioned. Nevertheless, some participants commented that
there was a need for educating news writers about the drug
(s), in order for them to write proper messages about the
drug. Wrong messages are likely to divert attention of the
people in the wrong direction and hence create a lot of
fear with an increased negative perception about the drug
in use or to be used. Thus, there is a need for both inter-
vening and doing more research in this area of assessing
the quality of messages sent out to consumers, the way
messages diffuse out in the rural communities of Tanzania
and the way they are perceived if we are aiming to
improve future communication strategies for any new
anti-malarial drug policy change to follow early next year
in Tanzania.
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